FDA — Fidia SpA Share News
0.000.00%
- €15.49m
- €19.02m
- €30.53m
Brief: Fidia FY Net Profit Eur 1 Mln
Sarepta falls on lower quarterly sales for gene therapy
Brief: Fidia Appoints Roberto Iammarino As CFO
Brief: Fidia Says Consob Authorizes Shares Linked To Convertible Bond Loan To Euronext Milan
ImmunityBio soars after FDA seeks details for wider use of bladder cancer drug
Brief: Fidia Approves EUR 5 Mln Convertible Bond Issuance
Brief: Fidia Terminates Contract With CFO Luca Carante
Brief: Fidia H1 Net Loss EUR 150,000
Brief: Fidia FY Net Loss At EUR 9.4 Mln, Appoints New CFO
Brief: Fidia FY EBITDA Negative For EUR 4.9 Mln
Brief: Fidia CFO Gianpiero Orlando To Step Down On May 19
Brief: Fidia Approves Reverse Stock Split With 1:100 Ratio
Brief: Fidia Prelim FY Revenue EUR 17.5 Mln
OS Therapies rises after starting commercial production of cancer therapy
Brief: Fidia Says Ivrea Court Issued Declaratory Order Of Dismissal Due To Completion Of Arrangement Procedure
Brief: Fidia To Issue New Shares In Line With EU Listing Act
Brief: Fidia Chairman Calls Board Meeting To Launch Fund Raising Initiatives
Brief: Fidia H1 Net Loss EUR 7.2 Mln, Trims FY Guidance
Brief: Fidia Appoints Augusto Mignani New CEO After Marco Livelli Resigns From Role